Establishment of a homogeneous chemiluminescence immunoassay for cat dander sIgE antibody detection

J Asthma. 2024 Jan;61(1):10-19. doi: 10.1080/02770903.2023.2234994. Epub 2023 Jul 14.

Abstract

Background: In vitro specific IgE (sIgE) testing has become an important tool for the diagnosis of IgE-mediated allergic diseases. Current methods used to detect allergen sIgE are time consuming and/or expensive. Therefore, a new method was developed for rapid quantitative detection of cat dander-sIgE antibody based on homogeneous chemiluminescence immunoassay.

Methods: Selection of chemibeads with different chemical groups, and the best Light-initiated chemiluminescence assay (LiCA) analytical mode for cat dander-sIgE detection. To validate and eliminate the interference of IgE on the detection of cat dander-sIgE, concentration of biotinylated anti-human IgE antibody was optimized. For quantification of cat dander-sIgE, a calibration curve was established, and the performance of the assay was evaluated according to clinical guidelines.

Results: Indirect LiCA is the best mode of analysis and biotinylated anti-human IgE antibody at a dilution ratio of 1:250 minimizes IgE interference. The coefficient of variation of the developed LiCA was 1.49% to 4.66%, with an intermediate precision of 6.90% to 8.21%. The LoB, LoD, and LoQ of the assay were 0.023 kUA/L, 0.056 kUA/L and 0.185 kUA/L. The coefficient of correlation (r) between LiCA and ImmounoCAP was 0.9478.

Conclusions: A cat dander-sIgE quantitation assay based on homogeneous chemiluminescence immunoassay was established, which could be a new reliable analytical tool for the determination of cat dander-sIgE.

Keywords: Cat dander allergy; Interference; Light-initiated chemiluminescence test; Specific IgE; Total IgE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens*
  • Asthma*
  • Dander
  • Humans
  • Immunoassay / methods
  • Immunoglobulin E
  • Immunosuppressive Agents
  • Luminescence

Substances

  • Allergens
  • Immunoglobulin E
  • Immunosuppressive Agents